SCHEMBL23510074

SCHEMBL23510074

Fc1cc(Cl)ccc1-n1c2ccccc2c2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 1/20 0.45
GRM2 Q14416 2/20 0.40
DRD4 P21917 1/20 0.40
KDM4E B2RXH2 3/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
ATM Q13315 1/20 0.39
ALDH1A1 P00352 1/20 0.39
APAF1 O14727 1/20 0.38
MEN1 O00255 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
GLA P06280 1/20 0.38
HTT P42858 1/20 0.37
AOC3 Q16853 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4D Q08499 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23510259 0.91 L3MBTL1 (0.41) SLC22A12KDM4EL3MBTL1ATMALDH1A1
SCHEMBL17950298 0.81 GLA (0.50) KDM4EL3MBTL1ATMALDH1A1APAF1
SCHEMBL13866720 0.81 L3MBTL1 (0.42) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL25844972 0.79 KDM4E (0.39) KDM4EL3MBTL1ATMALDH1A1APAF1
SCHEMBL23740164 0.79 GLA (0.41) KDM4EL3MBTL1ATMALDH1A1GLA
SCHEMBL24495915 0.78 ALDH1A1 (0.52) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL30634063 0.78 ALDH1A1 (0.52) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL13252844 0.78 KDM4E (0.42) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL17950300 0.78 L3MBTL1 (0.50) KDM4EL3MBTL1ATMALDH1A1APAF1
SCHEMBL29134583 0.77 KDM4E (0.45) KDM4EL3MBTL1ATMALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210184132-A1 COMPOUND, COMPOSITION INCLUDING THE SAME, LIQUID COMPOSITION, AND ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210184132-A1 COMPOUND, COMPOSITION INCLUDING THE SAME, LIQUID COMPOSITION, AND ORGANIC ELECTROLUMINESCENT DEVICE TERT, TELO2, POT1 SLC22A12 3938/4885GRM2 3836/4885DRD4 1505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.